Frederic Chereau

Frederic currently serves as the President and Chief Executive Officer of LogicBio (Nasdaq: LOGC), a clinical-stage genetic medicines company pioneering gene editing and delivery platforms to address rare and serious diseases. He has more than 25 years of executive leadership and industry experience in biotechnology, pharmaceuticals, and medical devices.

Prior to LogicBio, Frederic worked at Genzyme, Pervasis Therapeutics, Shire, and aTyr Pharma as General Manager, President & CEO, Senior Vice President, and COO respectively. Frederic holds a BSc in Physics, and an MSc in Management and completed his MBA at INSEAD, Fontainebleau, France.